181 related articles for article (PubMed ID: 30877067)
1. Calculation of drug-polymer mixing enthalpy as a new screening method of precipitation inhibitors for supersaturating pharmaceutical formulations.
Price DJ; Nair A; Kuentz M; Dressman J; Saal C
Eur J Pharm Sci; 2019 Apr; 132():142-156. PubMed ID: 30877067
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of HPMCAS during loading of glibenclamide onto mesoporous silica improves dissolution and inhibits precipitation.
Price DJ; Nair A; Becker-Baldus J; Glaubitz C; Kuentz M; Dressman J; Saal C
Eur J Pharm Sci; 2020 Jan; 141():105113. PubMed ID: 31655207
[TBL] [Abstract][Full Text] [Related]
3.
Koehl NJ; Henze LJ; Bennett-Lenane H; Faisal W; Price DJ; Holm R; Kuentz M; Griffin BT
Mol Pharm; 2021 Jun; 18(6):2174-2188. PubMed ID: 33890794
[TBL] [Abstract][Full Text] [Related]
4. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
Suys EJA; Chalmers DK; Pouton CW; Porter CJH
Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
[TBL] [Abstract][Full Text] [Related]
5. Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations - a PEARRL review.
Price DJ; Ditzinger F; Koehl NJ; Jankovic S; Tsakiridou G; Nair A; Holm R; Kuentz M; Dressman JB; Saal C
J Pharm Pharmacol; 2019 Apr; 71(4):483-509. PubMed ID: 29770440
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Intra- and Interlaboratory Reproducibility of a Small Scale Standardized Supersaturation and Precipitation Method.
Plum J; Madsen CM; Teleki A; Bevernage J; da Costa Mathews C; Karlsson EM; Carlert S; Holm R; Müller T; Matthews W; Sayers A; Ojala K; Tsinsman K; Lingamaneni R; Bergström CA; Rades T; Müllertz A
Mol Pharm; 2017 Dec; 14(12):4161-4169. PubMed ID: 29043811
[TBL] [Abstract][Full Text] [Related]
7. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica-based dosage forms improve release characteristics of poorly soluble drugs: case example fenofibrate.
Dressman JB; Herbert E; Wieber A; Birk G; Saal C; Lubda D
J Pharm Pharmacol; 2016 May; 68(5):634-45. PubMed ID: 26255860
[TBL] [Abstract][Full Text] [Related]
9. Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement.
Quan G; Niu B; Singh V; Zhou Y; Wu CY; Pan X; Wu C
Int J Nanomedicine; 2017; 12():8801-8811. PubMed ID: 29263669
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
11. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations.
Gosangari S; Dyakonov T
Pharm Dev Technol; 2013; 18(2):475-80. PubMed ID: 22881446
[TBL] [Abstract][Full Text] [Related]
12. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
McCarthy CA; Faisal W; O'Shea JP; Murphy C; Ahern RJ; Ryan KB; Griffin BT; Crean AM
J Control Release; 2017 Mar; 250():86-95. PubMed ID: 28132935
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the light scattering and the turbidity microtiter plate-based methods for the detection of the excipient-mediated drug precipitation inhibition.
Petruševska M; Urleb U; Peternel L
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1148-56. PubMed ID: 24056092
[TBL] [Abstract][Full Text] [Related]
14. Insights on role of polymers in precipitation of celecoxib from supersaturated solutions as assessed by focused beam reflectance measurement (FBRM).
Sodhi I; Mallepogu P; Thorat VP; Kashyap MC; Sangamwar AT
Eur J Pharm Sci; 2019 Sep; 137():104983. PubMed ID: 31271876
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the structural determinants of polymeric precipitation inhibitors using solvent shift methods and principle component analysis.
Warren DB; Bergström CA; Benameur H; Porter CJ; Pouton CW
Mol Pharm; 2013 Aug; 10(8):2823-48. PubMed ID: 23631696
[TBL] [Abstract][Full Text] [Related]
16. A study of hydrophobic domain formation of polymeric drug precipitation inhibitors in aqueous solution.
Zeneli E; Lange JJ; Holm R; Kuentz M
Eur J Pharm Sci; 2024 Jul; 198():106791. PubMed ID: 38705420
[TBL] [Abstract][Full Text] [Related]
17. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
[TBL] [Abstract][Full Text] [Related]
18. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.
Van Speybroeck M; Mellaerts R; Mols R; Thi TD; Martens JA; Van Humbeeck J; Annaert P; Van den Mooter G; Augustijns P
Eur J Pharm Sci; 2010 Dec; 41(5):623-30. PubMed ID: 20850527
[TBL] [Abstract][Full Text] [Related]
19. Studying the Propensity of Compounds to Supersaturate: A Practical and Broadly Applicable Approach.
Palmelund H; Madsen CM; Plum J; Müllertz A; Rades T
J Pharm Sci; 2016 Oct; 105(10):3021-3029. PubMed ID: 27488902
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica-based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate.
O'Shea JP; Nagarsekar K; Wieber A; Witt V; Herbert E; O'Driscoll CM; Saal C; Lubda D; Griffin BT; Dressman JB
J Pharm Pharmacol; 2017 Oct; 69(10):1284-1292. PubMed ID: 28631822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
